Drugmakers that develop new antibiotics are set to benefit from longer market protection in Europe after the EU agreed Thursday to a wide-ranging reform of pharmaceutical rules seeking to boost innovation and tackle antimicrobial resistance.
Continue Reading
News Source: medicalxpress.com
Leave a Reply